First, we confirmed that combined inhibition of OGT and CDK9 selectively inhibits proliferation of prostate cancer cells but does not have effects on normal prostate cells, as previously reported [23] (Additional file 1: Fig. S1). This evidence concerns the gene CDK9 and Familial prostate cancer.